HPV Vaccine Post-Surgery Cuts Viral Persistence
The administration of the human papillomavirus nonavalent (9vHPV) vaccine after a surgical treatment for low- and high-grade cervical intraepithelial neoplasia resulted in a significant reduction in the proportion of women positive for HPV over the 15-month study period.
METHODOLOGY:
Researchers conducted a retrospective study to examine the effectiveness of the 9vHPV vaccine after surgical treatment in women with cervical intraepithelial neoplasia.
They included 326 women (mean age, 40.7 years) who underwent carbon dioxide laser ablation for low-grade cervical intraepithelial neoplasia (CIN1) or the loop electrosurgical excision procedure for high-grade lesions (CIN2-3) between 2020 and 2024 at a centre in Italy.
Participants were divided into two groups: Vaccinated (n = 222) and unvaccinated (n = 104) groups; the vaccinated group received the 9vHPV vaccine either before surgery or within 30 days post-surgery.
Patients were followed up at 6 and 15 months post-treatment; HPV test results and colposcopy findings were analysed to determine the effect of vaccination on viral clearance.
TAKEAWAY:
During the 6-month follow-up period, HPV positivity rates were significantly lower for patients with CIN1 in the vaccinated group than for those in the unvaccinated group (18% vs 38%; P = .0169). The findings were consistent at the 15-month follow-up.
= .0169). The findings were consistent at the 15-month follow-up. During the 15-month follow-up period, HPV positivity rates were significantly lower for patients with CIN2-3 in the vaccinated group than for those in the unvaccinated group (8% vs 18%; P = .0353).
= .0353). Vaccination showed a significant effect in reducing HPV positivity among women aged 40 years or older with CIN1 ( P = .0100).
= .0100). At the end of the follow-up, post-treatment colposcopy findings were comparable between the groups, regardless of vaccination status.
IN PRACTICE:
"A comprehensive approach to cervical cancer prevention — including primary prevention (prophylactic vaccination), secondary prevention (cervical screening), and tertiary prevention (therapeutic interventions and post-treatment vaccination) — could play a crucial role in accelerating the elimination of cervical cancer worldwide," the authors wrote.
SOURCE:
This study was led by Mario Palumbo, School of Medicine, University of Naples "Federico II," Naples, Italy. It was published online on April 19, 2025, in the European Journal of Obstetrics & Gynecology and Reproductive Biology .
LIMITATIONS:
This study was limited by its retrospective observational study design.
DISCLOSURES:
This study did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The authors reported having no conflicts of interest or personal relationships that could have influenced the study.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 hours ago
- Yahoo
RFK Jr. removes all current members of CDC vaccine advisory committee
US Health and Human Services Secretary Robert F. Kennedy Jr. on Monday dismissed an expert panel of vaccine advisers that has historically guided the federal government's vaccine recommendations, saying the group is 'plagued with conflicts of interest.' The entirety of the 17-member Advisory Committee for Immunization Practices, which advises the US Centers for Disease Control and Prevention on the vaccine schedule and required coverage of immunizations, will be retired and replaced with new members, Kennedy announced in a Wall Street Journal op-ed. The HHS secretary has authority to appoint and dismiss ACIP members, who typically serve four-year cycles. But removing the entire panel prematurely is unprecedented. Kennedy said that a number of the panel's members — traditionally pediatricians, epidemiologists, immunologists and other physicians — were 'last-minute appointees' of the Biden administration. 'Without removing the current members, the current Trump administration would not have been able to appoint a majority of new members until 2028,' he wrote. ACIP members are not political appointees. However Kennedy, a longtime critic of federal vaccine policy and vaccine safety, argued that the current group is rife with conflicts of interest and has not been transparent in its vaccine recommendations. ACIP recently considered narrowing the recommendations for Covid-19 vaccinations among children. Kennedy had previously pledged to Sen. Bill Cassidy, a Republican from Louisiana and chairman of the Health, Education, Labor and Pensions Committee, that he would consult with the senator on filling key roles on vaccine advisory boards. A spokesperson for Cassidy did not immediately respond to a request for comment. The committee is scheduled to meet on June 25 to discuss vaccinations against Covid-19, RSV, influenza, HPV and meningococcal disease. HHS said the meeting will still take place, giving the agency roughly two weeks to fill its advisory panel. 'Appointing people this fast means they were not properly vetted, and there is no real time to check conflict of interests issues,' Dorit Reiss, a professor of law at UC Law San Francisco, told CNN. 'This will not restore trust in vaccines, and is not design to do so.'
Medscape
4 days ago
- Medscape
Medscape at 30: Three Decades of Big Events in Medicine
Medscape turns 30 in 2025. To mark this milestone, the Medscape 2050 project looks at what the field of medicine may look like 25 years from now. But the future is also shaped by the past. Below we look at the previous 30 years through the lens of Medscape News' coverage of the headlines and events that helped define medicine since 1995. May 22, 1995: Medscape Launches Remember what the early days of the internet were like? That's Medscape, launched out of a tiny office in Manhattan on May 22, 1995, by a scrappy group of people who had a great idea for a website to serve a physician readership. Here's what those early days were like. 1996: Highly Active Antiretroviral Therapy (HAART) Revolutionizes HIV/AIDS Treatment John G. Bartlett, MD, offers a thorough breakdown of HAART's evolution, with notable mention of a certain director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (NIH), Anthony Fauci. Ten years after this breakthrough, Medscape continued in-depth coverage, including this long Q&A with Richard Elion, MD. March 27, 1998: Viagra Approved by the FDA The first oral treatment for erectile dysfunction became a cultural phenomenon and, from a news perspective, the gift that kept on giving, leading to ongoing coverage not just in the ensuing years but for decades — including evidence 26 years later that the little blue pill may help prevent Alzheimer's. 1999: Vioxx and COX-2 Inhibitors Introduced The arrival of the new class of painkillers was less newsworthy than what followed later, with Vioxx linked to heart risks and pulled from the market. The fallout brought harsh questions about its initial FDA approval. March 2003: SARS Outbreak The global epidemic led to the first modern pandemic response, and just like the pandemic that would follow 17 years later, it spurred ongoing Medscape coverage that may seem quaint in retrospect. May 2005: Medscape Celebrates 10 Years Our 10th anniversary brought a comprehensive reckoning of some of the major medical advances from 1995 to 2004, including analysis of impactful stories across all specialties. November 24-25, 2005: First Successful Face Transplant Performed A new day for reconstructive surgery when surgeons grafted the donor nose, lips, and chin to the face of a 38-year-old French woman whose lips and nose were ripped off in a dog attack. The breakthrough procedure led to a sharp debate about whether the surgery should have happened at all. 2009: H1N1 (Swine Flu) Pandemic Six years after SARS, H1N1 gave us the first official flu pandemic in decades, prompting massive vaccine production, as well as inevitable comparisons to the 1918 pandemic, with the two strains, separated by 91 years, sharing similar features. March 23, 2010: Affordable Care Act (ACA) Signed Into Law in the US President Obama's signature legislation was a seismic health policy shift increasing insurance access. The law has been scrutinized (and challenged) ever since. Meanwhile, more than 24 million people signed up for ACA Marketplace Coverage for 2025, a new record. 2013: Angelina Jolie's BRCA1 Op-ed Spurs Genetic Testing Boom Celebrities can single-handedly transform public discourse on health issues, and Jolie did just that with hereditary cancer risk. As a result of the 'Angelina Jolie Effect,' BRCA testing doubled. 2014: Ebola Outbreak in West Africa While the outbreak highlighted weaknesses in global public health infrastructure, Medscape highlighted what US clinicians needed to know — as well as what they didn't know. In September, the WHO convened a 2-day meeting in Geneva to discuss therapies derived from survivors' blood. October 26, 2019: US Declares Opioid Epidemic a National Health Emergency Addiction treatment, regulation, and pharmaceutical accountability all became part of public medical discourse as part of the outcry to declare a state of emergency on opioids. President Trump eventually declared the crisis a national public health emergency. In 2019, opioid-related deaths reached almost 72,000, a new high. Death rates continued to rise well into 2020. 2019: Measles Outbreaks Reemerge Due to Vaccine Hesitancy A global spike in cases, especially in the US and Europe, foreshadowed measles news in 2025, but physicians were just as concerned then about the measles and vaccine hesitancy. 2020: COVID-19 Global Pandemic Declared Perhaps the biggest medical news event in Medscape's history, and as you can see, this selection of six headlines offers a telling timeline of just what was going on — what we knew and a whole lot we didn't…. March 11, 2020, WHO declares COVID-19 a pandemic So You Have a COVID-19 Patient; How Do You Treat Them? COVID-19: Time to 'Take the Risk of Scaring People' A Decade of Telemedicine Policy Has Advanced in Just 2 Weeks Year of COVID: Everything We Thought We Knew Was Wrong 'Death by 1000 Cuts': Medscape National Physician Burnout & Suicide Report 2021 June 24, 2022: US Overturns Roe v. Wade (Dobbs Decision) One of the most impactful legal decisions in US history with major implications for reproductive healthcare. Aside from the news itself, the decision spurred Medscape coverage on both sides of the issue in the medical world. Ob/Gyns on the Day That Roe v. Wade Was Overturned Pro-Life Ob/Gyns Say Dobbs Not End of Abortion Struggle Roe v. Wade : Medical Groups React to Supreme Court Decision February 2025: Trump Administration Announces Significant Cuts to Medical Research Funding The administration imposed a 15% cap on 'indirect costs' for NIH grants, reducing funds allocated for overhead expenses such as facilities and administrative support. But that was just one aspect of the cuts announced, reversed, or left in place, causing fear and uncertainty in the medical science community. What Happens When Science Stops Exodus of Infectious Disease Experts Imperils Public Safety Exclusive-Trump Health Layoffs Include Staff Overseeing Bird Flu Response, Source Says 2025: Measles Outbreak Response Hindered by Confusion A surge in measles cases across several states drove Medscape coverage, aiding clinicians who may have never seen a case of measles in their career while also detailing just how unprepared physicians and public health officials are for this widening crisis.
Forbes
4 days ago
- Forbes
University Of Chicago Receives $21 Million Gift For Quantum Medicine
The University of Chicago is establishing a new center on quantum biology and medicine, thanks to a ... More $21 million gift by Thea Berggren. The University of Chicago has been given a $21 million private donation to establish a new center focused on merging quantum engineering with biology in the search for medical breakthroughs. The gift is from philanthropist Thea Berggren, who will be recognized by naming the the initiative the Berggren Center for Quantum Biology and Medicine. 'The establishment of the Berggren Center reflects a commitment to a powerful idea: that the deepest scientific insights often emerge when we bring distinct disciplines together in bold new ways,' said University of Chicago President Paul Alivisatos, in a news release. 'Combining quantum engineering with medicine, the work of the center stands to transform our understanding of health and disease. Housed within the University of Chicago Pritzker School of Molecular Engineering, the new center will be an interdisciplinary effort that brings together quantum physicists, engineers and clinicians. Those investigators will attempt "to harness the power of quantum engineering — capable of the most sensitive measurements known to science — to peer inside the human body in unprecedented ways." The goal is to develop new diagnostic tools and therapies that will be more finely tuned, offering the chance of personalized interventions for diseases like cancer. Those goals have recently come within reach because of advances in quantum science that enable very precise measurements of molecular and cellular activity within the human body. Through the use of quantum sensors, researchers can now observe biochemical activity that has not been detectable via prior imaging techniques, making it possible to translate quantum advances into clinical solutions. The center will be co-directed by Greg Engel, Professor in the Pritzker School of Molecular Engineering and the Department of Chemistry and Julian Solway, the Walter L. Palmer Distinguished Service Professor for Medicine and Pediatrics and the Director of the university's Institute for Translational Medicine. The pair have previously collaborated on research concerning the use of quantum imaging tools. 'Fusing quantum physics and medicine is no small feat, but it opens the door to tools and discoveries we never thought possible,' said Engel. 'This gift will help unite two very different scientific cultures in a common mission to improve human health.' The University of Chicago has become a global leader in quantum science and engineering, serving as the hub of the Chicago Quantum Exchange, a multi-partner international effort that is advancing the quantum future. The University also is part of a research and development ecosystem that includes one of the biggest quantum testbeds in the country; the first U.S. business incubator focused exclusively on quantum; and the Illinois Quantum and Microelectronics Park, which will be built on Chicago's South Side. The Berggren gift includes both endowed funds and money for current support. It will be used to fund several activities, including fellowships to train interdisciplinary scholars, technical development projects, and conferences brining together scholars in quantum biology and medicine. 'During a visit to the Atacama Desert, I engaged with astronomers from around the world, and all were inspired by how quantum mechanics is shaping the future, said Berggren in the university's announcement. 'That moment sparked a different question: What if we applied the same quantum principles to cellular physiology and pathology? The potential to transform medicine and how we understand and treat disease is extraordinary, and the University of Chicago is the ideal place to bring this vision to life.'
